SCHEMBL8128995

SCHEMBL8128995

Cc1cc(-c2noc(C3CC3)n2)cc(C)c1OCCCc1cc(O)no1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.53
CYP3A4 P08684 2/20 0.53
NR1I2 O75469 1/20 0.53
RAB9A P51151 4/20 0.38
NPC1 O15118 3/20 0.38
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
AOC3 Q16853 2/20 0.37
GAA P10253 3/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 2/20 0.35
MAPK1 P28482 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
KIT P10721 1/20 0.35
CA12 O43570 3/20 0.34
CA1 P00915 3/20 0.34
CA2 P00918 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8136233 0.89 CYP2D6 (0.66) CYP2D6CYP3A4NR1I2RAB9ANPC1
SCHEMBL8135581 0.89 CYP3A4 (0.52) CYP2D6CYP3A4NR1I2RAB9ANPC1
SCHEMBL8875601 0.88 CYP2D6 (0.53) CYP2D6CYP3A4NR1I2RAB9ANPC1
SCHEMBL8135362 0.87 CYP2D6 (0.50) CYP2D6CYP3A4NR1I2RAB9ANPC1
SCHEMBL8132486 0.86 CYP2D6 (0.51) CYP2D6CYP3A4NR1I2RAB9ANPC1
SCHEMBL8132503 0.84 CYP3A4 (0.62) CYP2D6CYP3A4NR1I2RAB9ANPC1
SCHEMBL9177755 0.84 CYP2D6 (0.49) CYP2D6CYP3A4NR1I2RAB9ANPC1
SCHEMBL9523316 0.79 NR1I2 (0.54) CYP2D6CYP3A4NR1I2L3MBTL1
SCHEMBL8129872 0.78 CYP2D6 (0.41) CYP2D6CYP3A4NR1I2RAB9ANPC1
SCHEMBL9173291 0.76 NR1I2 (0.49) CYP2D6CYP3A4NR1I2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0566199-B1 1,2,4-Oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents SANOFI SA (FR) 2000-03-01 EP disclosed
US-5643929-A TREATMENT OF PICORNAVIRAL OR RHINOVIRUS AND CHEMICAL INTERMEDIATES SANOFI WINTHROP, INC. (US) 1997-07-01 US disclosed
US-5464848-A 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents STERLING WINTHROP INC. (US) 1995-11-07 US disclosed
US-5349068-A 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents STERLING WINTHROP INC. (US) 1994-09-20 US disclosed
EP-0566199-A1 1,2,4-Oxadiazolyl-phenoxyalkylisoxazoles and their use a s antiviral agents STERLING WINTHROP INC. (US) 1993-10-20 EP disclosed